Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohammed Alaidarous has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Chemical and Biological Investigation of the Endophytic Aspergillus terreus (SU5) Inhabiting Date Fruits (Phoenix dactylifera)

    by Ahmed Abdel-Hadi, Mohammed Alaidarous, Abdulrahman Alatiq, Yahya Madkhali, Saeed Banawas, Mohamed Abouelela, Abdallah Hassane

    Endophytic fungi associated with date fruits (Phoenix dactylifera) are mostly under-explored, despite their potential as reservoirs of natural compounds. The aims of this study were to characterize the endophytic fungus Aspergillus terreus (SU5) isolated from date fruits, and to investigate its biological activities and chemical profile for the first time. Morphological and molecular methods were utilized to identify Aspergillus terreus. A liquid chromatography–mass spectrometry analysis (LC/MS/MS) was conducted to determine the chemical profile of the crude extract. Biological properties were investigated through acetylcholine esterase and butyrylcholine esterase inhibition, cytotoxicity assays against MCF-7 and MCF-7/Adr, and antioxidant assays. LC/MS/MS of the fungal extract resulted in the detection of 39 of established secondary metabolites, primarily comprising polyketides, quinones, and phenolic derivatives. The crude extract demonstrated significant antioxidant activity, especially in the ABTS assay (IC50 = 50.18 μg/mL), considerable cytotoxicity against MCF-7 breast cancer cells, diminished efficacy against the drug-resistant MCF-7/Adr cell line, and preferential inhibition of butyrylcholinesterase compared to acetylcholinesterase. While none of the identified compounds are novel, numerous metabolites are documented here for the first time from an endophytic A. terreus associated with date fruits. The findings underscore date fruits as a prospective ecological niche for a chemically varied endophytic fungus with potential pharmaceutical significance.


  • Open Access

    Incidence and Antibiotic Susceptibility of Gram‐Negative Bacteria Associated With Chest Infections in Intensive Care Unit Patients From a Selected Hospital in the Kingdom of Saudi Arabia

    by Afrah Almouwlid, Kamal Albenasy, Yasser Kamel, Abdelrahman Abdelmoktader, Mohammed Alaidarous, Ahmed Abdel-Hadi

    Background: Hospital‐acquired pneumonia (HAP), including ventilator‐associated pneumonia (VAP), is a leading cause of morbidity and mortality in intensive care units (ICUs). Local, organism‐specific antimicrobial resistance data are critical to guide empiric therapy and strengthen antimicrobial stewardship efforts. Objective: The aim of this study is to describe the spectrum of Gram‐negative bacilli (GNB) responsible for ICU‐acquired lower respiratory tract infections (LRTIs) in a Saudi general hospital and to characterize their antimicrobial resistance profiles, including multidrug‐resistant (MDR), extensively drug‐resistant (XDR), and pandrug‐resistant (PDR) patterns. Methods: We retrospectively analyzed 271 nonduplicate GNB isolates recovered from ICU respiratory specimens (sputum, tracheal aspirates, and throat swabs) collected between 2020 and 2022. Demographic characteristics, specimen distribution, bacterial species, and antimicrobial susceptibility patterns were summarized. MDR, XDR, and PDR classifications were determined according to standard phenotypic criteria. Results: Of the 271 specimens, 126 (46%) were sputum, 108 (40%) were tracheal aspirates, and 37 (14%) were throat swabs. Patients were 52% male (141/271) and 48% female (130/271), with 56% aged > 65 years. Twenty‐three GNB species were identified; the predominant pathogens were Klebsiella spp. (92/271, 34.0%), Pseudomonas spp. (73/271, 27.0%), and Acinetobacter spp. (32/271, 12%). Enterobacteriaceae accounted for 130 isolates (48.0%), while non‐Enterobacteriaceae comprised 141 (52.0%). There were statistically significant ( p = 0.016) differences between the three most common organisms ( Klebsiella pneumoniae , Pseudomonas aeruginosa , and Acinetobacter baumannii complex). Antimicrobial susceptibility testing revealed extensive resistance patterns across the major isolates. Pseudomonas spp. demonstrated very high resistance to cephalosporins (> 95%), with lower resistance observed to amikacin (43%). Acinetobacter spp. showed the most alarming profile, with nearly universal resistance to β ‐lactams and carbapenems (> 90%), although colistin retained complete activity (0% resistance). In contrast, Klebsiella spp. exhibited high resistance to third‐generation cephalosporins (86%–93%) and carbapenems (70%–77%) while maintaining moderate susceptibility to amikacin (45%) and tigecycline (36%). These findings demonstrate a substantial burden of MDR among ICU GNB isolates, with colistin emerging as the only consistently effective therapeutic option. Conclusions: ICU cohort is dominated by a limited number of highly resistant GNB led by K. pneumoniae , P. aeruginosa , and A. baumannii . The cohort predominantly affects older adults (> 60 years), and the breadth of MDR/XDR/PDR underscores the urgency of rigorous antimicrobial stewardship, infection prevention, and rapid diagnostics to optimize empiric therapy.


  • Open Access

    Immunoinformatics-Based Identification of B and T Cell Epitopes in RNA-Dependent RNA Polymerase of SARS-CoV-2

    by Shabir Ahmad Mir, Mohammed Alaidarous, Bader Alshehri, Abdul Aziz Bin Dukhyil, Saeed Banawas, Yahya Madkhali, Suliman A. Alsagaby, Ayoub Al Othaim

    Introduction: The ongoing coronavirus disease 2019 (COVID-19), which emerged in December 2019, is a serious health concern throughout the world. Despite massive COVID-19 vaccination on a global scale, there is a rising need to develop more effective vaccines and drugs to curb the spread of coronavirus. Methodology: In this study, we screened the amino acid sequence of the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 (the causative agent of COVID-19) for the identification of B and T cell epitopes using various immunoinformatic tools. These identified potent B and T cell epitopes with high antigenicity scores were linked together to design the multi-epitope vaccine construct. The physicochemical properties, overall quality, and stability of the designed vaccine construct were confirmed by suitable bioinformatic tools. Results: After proper in silico prediction and screening, we identified 3 B cell, 18 CTL, and 10 HTL epitopes from the RdRp protein sequence. The screened epitopes were non-toxic, non-allergenic, and highly antigenic in nature as revealed by appropriate servers. Molecular docking revealed stable interactions of the designed multi-epitope vaccine with human TLR3. Moreover, in silico immune simulations showed a substantial immunogenic response of the designed vaccine. Conclusions: These findings suggest that our designed multi-epitope vaccine possessing intrinsic T cell and B cell epitopes with high antigenicity scores could be considered for the ongoing development of peptide-based novel vaccines against COVID-19. However, further in vitro and in vivo studies need to be performed to confirm our in silico observations.


  • Open Access

    Nobiletin as a Neuroprotectant against NMDA Receptors: An In Silico Approach

    by Sadaf Jahan, Neeru Singh Redhu, Arif Jamal Siddiqui, Danish Iqbal, Johra Khan, Saeed Banawas, Mohammed Alaidarous, Bader Alshehri, Shabir Ahmad Mir, Mohd Adnan, et al.

    Excitotoxicity is a type of neurodegenerative disorder. It caused by excessive glutamate receptor activation, which leads to neuronal malfunction and fatality. The N-methyl-D-aspartate (NMDA) receptors are found in glutamatergic neurons, and their excessive activation is primarily responsible for excitotoxicity. They are activated by both glutamate binding and postsynaptic depolarization, facilitating Ca2+ entry upon activation. Therefore, they are now widely acknowledged as being essential targets for excitotoxicity issues. Molecular docking and molecular dynamics (MD) simulation analyses have demonstrated that nobiletin efficiently targets the binding pocket of the NMDA receptor protein and exhibits stable dynamic behavior at the binding site. In this study, five potential neuroprotectants, nobiletin, silibinin, ononin, ginkgolide B, and epigallocatechin gallate (EGCG), were screened against the glutamate NMDA receptors in humans via computational methods. An in silico ADMET study was also performed, to predict the pharmacokinetics and toxicity profile for the expression of good drug-like behavior and a non-toxic nature. It was revealed that nobiletin fulfills the criteria for all of the drug-likeness rules (Veber, Lipinski, Ghose, Muegge, and Egan) and has neither PAINS nor structural alerts (Brenks). In conclusion, nobiletin demonstrated a possible promising neuroprotectant activities compared to other selected phytochemicals. Further, it can be evaluated in the laboratory for promising therapeutic approaches for in vitro and in vivo studies.


  • Brucellosis: An Investigation of the Knowledge, Attitudes and Behaviors Among a Selected Population in Majmaah Saudi Arab

    by Mohammed Alaidarous

    Brucellosis is a zoonotic bacterial disease carried by animals such as sheep, cows, and camels. It is transmitted to humans through the consumption of affected animals or their by-products. Dairy products form a major part of the Arabic diet and are very widely consumed in Saudi Arabia, where brucellosis is endemic. This study has analyzed the current knowledge, attitudes, and behaviors toward brucellosis of adults aged 18 years and older among Majmaah University students and staff. A cross-sectional study with 181 participants was conducted using an online survey during March–April 2021. The results showed that the majority of people knew about brucellosis and its transmission, but only a fraction of them took the required precautionary measures. This study highlights that knowledge alone is insufficient to promote healthy behaviors. It is thus important to raise awareness in a way that can convert knowledge into action.

  • Open Access

    Pioneer Role of Extracellular Vesicles as Modulators of Cancer Initiation in Progression, Drug Therapy, and Vaccine Prospects

    by Sadaf Jahan, Shouvik Mukherjee, Shaheen Ali, Urvashi Bhardwaj, Ranjay Kumar Choudhary, Santhanaraj Balakrishnan, Asma Naseem, Shabir Ahmad Mir, Saeed Banawas, Mohammed Alaidarous, et al.

    Cancer is one of the leading diseases, causing deaths worldwide. Nearly 10 million deaths were reported in 2020 due to cancer alone. Several factors are involved in cancer progressions, such as lifestyle and genetic characteristics. According to a recent report, extracellular vesicles (EVs) are involved in cancer initiation, progression, and therapy failure. EVs can play a major role in intracellular communication, the maintenance of tissue homeostasis, and pathogenesis in several types of diseases. In a healthy person, EVs carry different cargoes, such as miRNA, lncRNA etc., to help other body functions. On the other hand, the same EV in a tumor microenvironment carries cargoes such as miRNA, lncRNA, etc., to initiate or help cancer progression at various stages. These stages may include the proliferation of cells and escape from apoptosis, angiogenesis, cell invasion, and metastasis, reprogramming energy metabolism, evasion of the immune response, and transfer of mutations. Tumor-derived EVs manipulate by altering normal functions of the body and affect the epigenetics of normal cells by limiting the genetic makeup through transferring mutations, histone modifications, etc. Tumor-derived EVs also pose therapy resistance through transferring drug efflux pumps and posing multiple drug resistances. Such EVs can also help as biomarkers for different cancer types and stages, which ultimately help with cancer diagnosis at early stages. In this review, we will shed light on EVs’ role in performing normal functions of the body and their position in different hallmarks of cancer, in altering the genetics of a normal cell in a tumor microenvironment, and their role in therapy resistance, as well as the importance of EVs as diagnostic tools.


  • Open Access

    Molecular target prediction and docking of anti-thrombosis compounds and its activation on tissue-plasminogen activator to treat stroke

    by Bader Alshehri, Rajendran Vijayakumar, Subramanian Senthilkumar, Ahmed Ismail, Ahmed Abdelhadi, Ranjay K. Choudhary, Kamal S. Albenasy, Saeed Banawas, Mohammed A. Alaidarous, Palanisamy Manikandan


  • The Association of Anemia with Vitamin D Deficiency among Patients Visiting King Khalid General Hospital in Majmaah, Saudi Arabia

    by Muath Alanazi, Raed Alharbi, Saleh Aloyuni, Ranjay Choudhary, Wael Alturaiki, Saeed Banawas, Bader Alshehri, Mohammed A. Alaidarous

    Aims: To assess the association between vitamin D deficiency and anemia among patients visiting King Khalid General Hospital in Majmaah City, Saudi Arabia. Methodology: We reviewed the medical records of 120 patients (median age, male 37.44 [±17.86] and female 43.22 [±16.23] years; range 1–96 years) who attended the King Khalid General Hospital laboratory in Majmaah city, Saudi Arabia, between January 2019 and January 2020. The laboratory data included the following parameters: complete blood count (Hb, MCV, MCHC, MCH, Hct, WBC, RBC, and Plt) and vitamin D (25(OH)D) levels. Results: The chi-squared analysis showed that moderate anemia was highest among the participants who had vitamin D levels >30 ng/ml and less than 20 ng/ml, with a prevalence rate of 5% (n=6) for each category. Mild anemia was prevalent among 4.12% (n=5) of the participants with vitamin D levels Conclusion: There is a significant association between vitamin D deficiency and anemia among patients visiting King Khalid General Hospital in Majmaah City, Saudi Arabia.


  • Open Access

    Exploring the Binding Pattern of Geraniol with Acetylcholinesterase through In Silico Docking, Molecular Dynamics Simulation, and In Vitro Enzyme Inhibition Kinetics Studies

    by Danish Iqbal, M. Salman Khan, Mohd Waiz, Tabish Rehman, Mohammed Alaidarous, Azfar Jamal, Abdulaziz S. Alothaim, Mohamed F AlAjmi, Bader Mohammed Alshehri, Saeed Banawas, et al.

    Acetylcholinesterase (AChE) inhibition is a key element in enhancing cholinergic transmission and subsequently relieving major symptoms of several neurological and neuromuscular disorders. Here, the inhibitory potential of geraniol and its mechanism of inhibition against AChE were elucidated in vitro and validated via an in silico study. Our in vitro enzyme inhibition kinetics results show that at increasing concentrations of geraniol and substrate, Vmax did not change significantly, but Km increased, which indicates that geraniol is a competitive inhibitor against AChE with an IC50 value 98.06 ± 3.92 µM. All the parameters of the ADME study revealed that geraniol is an acceptable drug candidate. A docking study showed that the binding energy of geraniol (−5.6 kcal mol−1) was lower than that of acetylcholine (−4.1 kcal mol−1) with AChE, which exhibited around a 12.58-fold higher binding affinity of geraniol. Furthermore, molecular dynamics simulation revealed that the RMSD of AChE alone or in complex with geraniol fluctuated within acceptable limits throughout the simulation. The mean RMSF value of the complex ensures that the overall conformation of the protein remains conserved. The average values of Rg, MolSA, SASA, and PSA of the complex were 3.16 Å, 204.78, 9.13, and 51.58 Å2, respectively. We found that the total SSE of AChE in the complex was 38.84% (α-helix: 26.57% and β-sheets: 12.27%) and remained consistent throughout the simulation. These findings suggest that geraniol remained inside the binding cavity of AChE in a stable conformation. Further in vivo investigation is required to fully characterize the pharmacokinetic properties, optimization of dose administration, and efficacy of this plant-based natural compound.


  • Open Access

    Cerebroprotective effect of Aloe Emodin: In silico and in vivo studies

    by Praveen Kumar Pasala, Rizwaan Abbas Shaik, Mithun Rudrapal, Johra Khan, Mohammad A. Alaidarous, Shubham Jagdish Khairnar, Atul R. Bendale, Vaishali D. Naphade, Ranjan Kumar Sahoo, James H. Zothantluanga, et al.